FINLEY JOHN DAVID

PrivateCIK: 1851034
Location

GERMANTOWN, MD

FINLEY JOHN DAVID (Chief Financial Officer) sold 40.3% of their position (146.80K shares) of PALISADE BIO, INC. on the open market

Open‑market sale worth $303.3K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 1 sale
InsiderFINLEY JOHN DAVIDCIK 1851034
IssuerPALISADE BIO, INC.CIK 1357459
Officer· Chief Financial Officer
Since Apr 2021
-146.80K
Net shares
Net seller
$303.3K
Total sold
1
Open market trades
0B · 1S
5
Total transactions
335.30K acquired · 482.10K disposed
Non-Derivative Transactions3

Common Stock

Direct
M · Option Exercise

Shares

+335.17K

Price / share

Trade value

% of position

1148.4%
7/6/2026
29.19K364.35K

Common Stock

Direct
S · Sale

Shares

146.80K

Price / share

$2.07

Trade value

$303.34K

% of position

40.3%
7/7/2026
364.35K217.56K

Common Stock

Direct
M · Option Exercise

Shares

+133.00

Price / share

$0.70

Trade value

$93.10

% of position

0.1%
7/7/2026
217.56K217.69K
Total

Net shares

+188.50K

Net value

-$303.25K

Derivative Transactions2

Restricted Stock Units

Direct
M · Option Exercise
Converts to

Common Stock

335.17K shares

Shares

335.17K

Strike price

Held after

1.68M

Exercisable

7/6/2026

Series 2 Common Stock Purchase Warrant

Direct
M · Option Exercise
Converts to

Common Stock

133.00 shares

Shares

133.00

Strike price

0.70

Held after

0.00

Exercisable

7/7/2026
Non-Derivative Holdings (Post-Transaction)1

Common Stock

Indirect
Shares owned51.00
Total
51.00 indirect51.00
Derivative Holdings (Post-Transaction)0
No derivative holdings reported